“Lebrikizumab Treatment Improves Lichenification and Other Clinical Signs of Atopic Dermatitis in Adults and Adolescents With Moderate-to-Severe AD and Skin of Color”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s625, https://doi.org/10.25251/0262jz84.